» Articles » PMID: 109021

A Rat Model of Chronic Respiratory Infection with Pseudomonas Aeruginosa

Overview
Specialty Pulmonary Medicine
Date 1979 Mar 1
PMID 109021
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic, nonlethal, pulmonary infection of rats by Pseudomonas aeruginosa can be initiated by intratracheal inoculation of 10(4) bacteria enmeshed in agar beads. The number of bacteria recoverable from the lung increased to approximately 10(6) within 3 days and remained at that number during 35 days of observation. Histologic examination of the infected lungs revealed lesions resembling those seen in lung tissue of humans with acute or chronic nonbacteremic, Pseudomonas aeruginosa pneumonia, including the presence of goblet-cell hyperplasia, focal areas of necrosis, and acute and chronic inflammatory infiltrate. This model should be useful for investigating the interactions between microbial virulence factors and host defense mechanisms.

Citing Articles

Normalization of Muc5b ameliorates airway mucus plugging during persistent infection in the CFTR rat.

Murphree-Terry M, Keith J, Oden A, Birket S Am J Physiol Lung Cell Mol Physiol. 2024; 327(5):L672-L683.

PMID: 39316674 PMC: 11563644. DOI: 10.1152/ajplung.00381.2023.


population dynamics in a vancomycin-induced murine model of gastrointestinal carriage.

Lebrun-Corbin M, Cheung B, Hullahalli K, Dailey K, Bailey K, Waldor M bioRxiv. 2024; .

PMID: 39229171 PMC: 11370369. DOI: 10.1101/2024.08.19.608679.


Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection.

Pangeni R, Poudel S, Momin M, Farkas D, Dalton C, Hall F Int J Pharm. 2024; 662:124504.

PMID: 39053676 PMC: 11344668. DOI: 10.1016/j.ijpharm.2024.124504.


Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.

Yu H, Xu Y, Imani S, Zhao Z, Ullah S, Wang Q ACS Infect Dis. 2024; 10(7):2336-2355.

PMID: 38866389 PMC: 11249778. DOI: 10.1021/acsinfecdis.4c00007.


Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations.

Dartois V, Bonfield T, Boyce J, Daley C, Dick T, Gonzalez-Juarrero M Tuberculosis (Edinb). 2024; 147:102503.

PMID: 38729070 PMC: 11168888. DOI: 10.1016/j.tube.2024.102503.